Gilead Sciences (GILD) PT Lowered to $122 at RBC Capital
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $131.27 +4.21%
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams lowered the price target on Gilead Sciences (NASDAQ: GILD) to $122.00 (from $123.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Pembina Pipeline Corp. (PPL:CN) (PBA) PT Raised to Cdn$73 at CIBC
- Deutsche Lufthansa AG (LHA:GR) (DLAKY) PT Raised to EUR11 at UBS
- Societe BIC SA (BB:FP) (BICEY) PT Raised to EUR56 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
